418 Factors associated with HIV amongst migrant MSM in Europe

Abstract EP1.4, e-Poster Terminal 1, September 4, 2025, 11:35 - 13:00 Aims In 2022 migrants comprised 48% of all new HIV diagnoses in the EU/EEA and only four countries provided data across the care continuum for migrants. We sought to implement a HIV screening strategy for migrants in 10 European countries. Methods Between April 2022 – March 2023, we conducted the Mi-Health HIV Partnership, a study of migrants in 10 European countries (Belgium, Cyprus, England, France, Germany, Greece, Italy, Netherlands, Portugal, Sweden). HIV infection was determined by combined antibody/antigen, point-of-care, rapid blood or rapid oral test. Additional study variables were collected through a survey of all participants. Results We screened 2402 migrants and diagnosed 154 with HIV, a prevalence rate of 6.41%. Amongst the subset of migrants self-identifying as MSM (n = 413), 74 were diagnosed with HIV, a prevalence rate of 17.92%. Of the HIV-positive MSM, 64.86% identified as South/Central American, compared to 47.46% of all MSM sampled. Higher levels (90.54%) of HIV-positive MSM were linked into healthcare compared to all MSM (48.43%). Additionally, 10.82% of HIV-positive MSM reported no/limited access to healthcare as compared to 19.73% of all MSM with no/limited access. Substantially higher levels of HIV-positive MSM (47.30%) reported stigma/racism/discrimination as their primary barrier to healthcare access as compared to all MSM in our sample (34.14%). Markedly higher levels of HIV-positive MSM identified engaging in sex work or sex with a sex worker as their primary behavioural vulnerability as compared to all MSM (64.86% versus 35.59%, respectfully). Finally, HIV-positive MSM reported lower levels of both PrEP awareness (43.24%) and using PrEP at least once in the previous year (4.05%) as compared to all MSM (68.28% and 13.08%, respectfully). Conclusions HIV infection rates are higher amongst key population migrants. There is a need to implement community-led, targeted, culturally-sensitive screening, engagement and treatment strategies to address the multilevel barriers faced by migrants.

Authors

Institutions

Publication Details

Journal
European Journal of Public Health
Published
2025-12-01
DOI
https://doi.org/10.1093/eurpub/ckaf180.332
Primary Topic
HIV/AIDS Research and Interventions
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

418 Factors associated with HIV amongst migrant MSM in Europe

Trésors Gemaye Kouadio, Rosaline M’Bayo, Stephen Amoah, Filomena Frazão de Aguiar et al.
European Journal of Public Health
HIV/AIDS Research and Interventions
article

418 Factors associated with HIV amongst migrant MSM in Europe

Trésors Gemaye Kouadio, Rosaline M’Bayo, Stephen Amoah, Filomena Frazão de Aguiar, Denis Onyango, Luciano Nigro, Paul A. Lawson, Christos Krasidis, Zoe Kakota, Anne Flaherty-gupta, Kim Isip, Ian Robert Kibet Ouko Babu
article en

Abstract

Abstract EP1.4, e-Poster Terminal 1, September 4, 2025, 11:35 - 13:00 Aims In 2022 migrants comprised 48% of all new HIV diagnoses in the EU/EEA and only four countries provided data across the care continuum for migrants. We sought to implement a HIV screening strategy for migrants in 10 European countries. Methods Between April 2022 – March 2023, we conducted the Mi-Health HIV Partnership, a study of migrants in 10 European countries (Belgium, Cyprus, England, France, Germany, Greece, Italy, Netherlands, Portugal, Sweden). HIV infection was determined by combined antibody/antigen, point-of-care, rapid blood or rapid oral test. Additional study variables were collected through a survey of all participants. Results We screened 2402 migrants and diagnosed 154 with HIV, a prevalence rate of 6.41%. Amongst the subset of migrants self-identifying as MSM (n = 413), 74 were diagnosed with HIV, a prevalence rate of 17.92%. Of the HIV-positive MSM, 64.86% identified as South/Central American, compared to 47.46% of all MSM sampled. Higher levels (90.54%) of HIV-positive MSM were linked into healthcare compared to all MSM (48.43%). Additionally, 10.82% of HIV-positive MSM reported no/limited access to healthcare as compared to 19.73% of all MSM with no/limited access. Substantially higher levels of HIV-positive MSM (47.30%) reported stigma/racism/discrimination as their primary barrier to healthcare access as compared to all MSM in our sample (34.14%). Markedly higher levels of HIV-positive MSM identified engaging in sex work or sex with a sex worker as their primary behavioural vulnerability as compared to all MSM (64.86% versus 35.59%, respectfully). Finally, HIV-positive MSM reported lower levels of both PrEP awareness (43.24%) and using PrEP at least once in the previous year (4.05%) as compared to all MSM (68.28% and 13.08%, respectfully). Conclusions HIV infection rates are higher amongst key population migrants. There is a need to implement community-led, targeted, culturally-sensitive screening, engagement and treatment strategies to address the multilevel barriers faced by migrants.

European Journal of Public HealthVol. 35(Supplement_6)
Institut Pasteur (FR), Universidade do Porto (PT), Hellenic Open University (GR), University of Cyprus (CY), Istituto per lo Studio e la Prevenzione Oncologica (IT), The Ark (IE), Children's Advocacy Center (US), Lusíada University of Porto (PT), National Research Foundation (ZA), Sirris (BE)
Openalex Percentile: Top 55%
HIV/AIDS Research and Interventions
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.